CEO of Cyclo Therapeutics Inc (30-Year Financial, Insider Trades) N Scott Fine (insider trades) bought 730,030 shares of CTDH on 04/24/2020 at an average price of $0.1 a share. The total cost of this purchase was $73,003.
CTD Holdings Inc is engaged in marketing and sale of cyclodextrins (CD) and related products to food, pharmaceutical and other industries for use in diagnostics and specialty drugs with continuing growth in research and new product development. Cyclo Therapeutics Inc has a market cap of $20.380 million; its shares were traded at around $0.17 with and P/S ratio of 18.89. GuruFocus has detected 3 severe warning signs with Cyclo Therapeutics Inc. .
CEO Recent Trades:
- CEO N Scott Fine bought 730,030 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
Directors and Officers Recent Trades:
- Director Randall M. Toig bought 1,000,000 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
- Director Markus Sieger bought 500,000 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
- 10% Owner L.p. Novit, bought 2,000,000 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
- Director Francis Patrick Ostronic bought 1,000,000 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
- Director William S Shanahan bought 1,000,000 shares of CTDH stock on 04/24/2020 at the average price of $0.1.
For the complete insider trading history of CTDH, click here
.
